Rhenman & Partners Asset Management AB - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,888,500
-14.5%
50,0000.0%0.20%
-14.7%
Q3 2022$2,210,000
+19.4%
50,0000.0%0.23%
+10.0%
Q2 2022$1,851,000
-29.6%
50,000
-29.6%
0.21%
-18.9%
Q1 2022$2,630,000
+14.8%
71,000
-5.3%
0.26%
+70.4%
Q4 2021$2,291,000
-8.9%
75,0000.0%0.15%
-14.1%
Q3 2021$2,516,000
-15.9%
75,0000.0%0.18%
-12.8%
Q2 2021$2,992,000
-11.3%
75,0000.0%0.20%
-13.6%
Q1 2021$3,372,000
+30.1%
75,000
+17.2%
0.24%
-54.4%
Q1 2016$2,592,000
-37.5%
64,000
-4.5%
0.52%
-17.9%
Q4 2015$4,149,00067,0000.63%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders